Cargando…

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder

BACKGROUND: Concurrent therapeutic prescribing of prescription stimulants with opioid analgesics is increasing in the United States. Stimulant medication use is associated with increased risk for long-term opioid therapy (LTOT), and LTOT is associated with increased risk for opioid use disorder (OUD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scherrer, Jeffrey F., Salas, Joanne, Grucza, Richard, Wilens, Timothy, Quinn, Patrick D., Sullivan, Mark D., Rossom, Rebecca C., Wright, Eric, Piper, Brian, Sanchez, Katherine, Lapham, Gwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949323/ https://www.ncbi.nlm.nih.gov/pubmed/36844161 http://dx.doi.org/10.1016/j.dadr.2022.100122

Ejemplares similares

Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention’s Opioid Prescribing Guidelines
por: Scherrer, Jeffrey F., et al.
Publicado: (2020)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Contextualizing prescription opioid misuse and heroin use within dimensional models of drug involvement
por: Dash, Genevieve F., et al.
Publicado: (2022)

Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer
por: Bates, Nicole, et al.
Publicado: (2022)

Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain
por: Anderson Goodell, Erin M., et al.
Publicado: (2021)

The Prescription Opioids and Depression Pathways Cohort Study
por: Scherrer, Jeffrey F., et al.
Publicado: (2020)

Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder
por: Mintz, Carrie M., et al.
Publicado: (2022)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions
por: Scherrer, Jeffrey F., et al.
Publicado: (2023)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Under-representation of key demographic groups in opioid use disorder trials
por: Rudolph, Kara E., et al.
Publicado: (2022)

Negative attitudes about medications for opioid use disorder among criminal legal staff
por: Moore, Kelly E., et al.
Publicado: (2022)

A Preliminary Study of Stress, Mental Health, and Pain Related to the COVID-19 Pandemic and Odds of Persistent Prescription Opioid Use
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment
por: Pan, Yue, et al.
Publicado: (2022)

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder
por: Hefner, Kathryn, et al.
Publicado: (2022)

Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
por: Nordeck, Courtney D., et al.
Publicado: (2022)

The association between medication for opioid use disorder and employment outcomes in the U.S.: The relevance of race and ethnicity
por: Hoang, Bai Linh, et al.
Publicado: (2022)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States
por: Pollack, Harold A., et al.
Publicado: (2022)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021
por: Shearer, Riley D., et al.
Publicado: (2023)

What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size
por: Keyes, Katherine M., et al.
Publicado: (2022)

COVID-19 impact on opioid overdose after jail release in Massachusetts
por: Friedmann, Peter D., et al.
Publicado: (2023)

Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
por: Pickens, Cassandra M., et al.
Publicado: (2023)

Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field
por: O'Brien, Peggy L., et al.
Publicado: (2022)

A qualitative exploration of the eight dimensions of wellness in opioid use disorder recovery during the postpartum period
por: Mallahan, Stephanie, et al.
Publicado: (2023)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023)

Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review
por: Tetrault, Jeanette M., et al.
Publicado: (2015)

Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019
por: Ko, Jean Y., et al.
Publicado: (2020)

Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study
por: Martin, Anna K., et al.
Publicado: (2023)

Identifying mortality risks in patients with opioid use disorder using brief screening assessment: Secondary mental health clinical records analysis
por: Bogdanowicz, Karolina Magda, et al.
Publicado: (2016)

Similar COVID-19 incidence to the general population in people with opioid use disorder receiving integrated outpatient clinical care
por: Vallecillo, Gabriel, et al.
Publicado: (2022)

Listening to women and pregnant and postpartum people: Qualitative research to inform opioid use disorder treatment for pregnant and postpartum people
por: Guille, Constance, et al.
Publicado: (2022)

Opportunities to expand postpartum support for those in recovery from opioid use disorder: Results from a qualitative study
por: Allen, Alicia, et al.
Publicado: (2023)

Adolescent prescription opioid misuse, illicit opioid use and overdose
por: Bohm, Michele K., et al.
Publicado: (2019)

Validation and endorsement of health system performance measures for opioid use disorder in British Columbia, Canada: A Delphi panel study
por: Kamran, Hasham, et al.
Publicado: (2022)

Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose
por: Sosnowski, David W., et al.
Publicado: (2022)

Prescription opioid use in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

An observational study on the use of long acting buprenorphine (Sublocade) and a Tamper resistant PICC for Outpatient IV antibiotic administration in Patients with serious infections and Opioid Use Disorder; The STOP OUD project
por: Pineo, Thomas, et al.
Publicado: (2021)

Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder
por: Segura, Luis E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8rc21qk1spe453r3ffrev8lffg